Clinical Trials Logo

Clinical Trial Summary

A study to compare safety, pharmacokinetics and pharmacodynamics of AD-213-A to AD-2131 in healthy volunteers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04690868
Study type Interventional
Source Addpharma Inc.
Contact
Status Completed
Phase Phase 1
Start date October 15, 2021
Completion date December 21, 2021

See also
  Status Clinical Trial Phase
Completed NCT04755985 - A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132 Phase 1